{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:15:39Z","timestamp":1755216939497,"version":"3.43.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.japh.2025.102413","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:13:00Z","timestamp":1746533580000},"page":"102413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time to goal hemoglobin A1c with pharmacist management compared with nonpharmacist management"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9842-3317","authenticated-orcid":false,"given":"Olutuminiun","family":"Osunsanmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-7669","authenticated-orcid":false,"given":"Nolan","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Darkwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0952-9133","authenticated-orcid":false,"given":"Mallory","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Loucks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.japh.2025.102413_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of diabetes and diabetes-related complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys Ther"},{"issue":"5","key":"10.1016\/j.japh.2025.102413_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40258-018-0398-2","article-title":"Impact of reducing glycated hemoglobin on healthcare costs among a population with uncontrolled diabetes","volume":"16","author":"Bansal","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"10.1016\/j.japh.2025.102413_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s13300-022-01212-4","article-title":"The association between HbA1c and 1-year diabetes related medical costs: a retrospective claims database analysis","volume":"13","author":"Boye","year":"2022","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.japh.2025.102413_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.285.2.182","article-title":"Effect of improved glycemic control on health care costs and utilization","volume":"285","author":"Wagner","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.japh.2025.102413_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11606-022-07707-x","article-title":"Revisiting the time needed to provide adult primary care","volume":"38","author":"Porter","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.japh.2025.102413_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1331\/JAPhA.2015.14229","article-title":"Assessing pharmacist-led annual wellness visits: interventions made and patient and physician satisfaction","volume":"55","author":"Wilson","year":"2015","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.japh.2025.102413_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/jpbs.JPBS_138_19","article-title":"A review of pharmacist-led interventions on diabetes outcomes: an observational analysis to explore diabetes care opportunities for pharmacists","volume":"11","author":"Iqbal","year":"2019","journal-title":"J Pharm Bioallied Sci"},{"issue":"10","key":"10.1016\/j.japh.2025.102413_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/MLR.0b013e3181e57962","article-title":"U.S. pharmacists\u2019 effect as team members on patient care: systematic review and meta-analysis","volume":"48","author":"Chisholm-Burns","year":"2010","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.japh.2025.102413_bib11","first-page":"423","article-title":"The effect of clinical pharmacist-led comprehensive medication management on chronic disease state goal attainment in a patient-centered medical home","volume":"24","author":"Prudencio","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.japh.2025.102413_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jcpt.12536","article-title":"Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (Impact): a randomized controlled trial","volume":"42","author":"Siaw","year":"2017","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.japh.2025.102413_bib13","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/ijerph19063156","article-title":"Impact of pharmacists-led interventions in primary care for adults with type 2 diabetes on HbA1c levels: a systematic review and meta-analysis","volume":"19","author":"Coutureau","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.japh.2025.102413_bib14","first-page":"114","article-title":"Evaluation of a pharmacist-managed diabetes program in a primary care setting within an integrated health care system","volume":"24","author":"Benedict","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.japh.2025.102413_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24926\/iip.v9i2.985","article-title":"Impact of pharmacist-led diabetes management in primary care clinics","volume":"9","author":"Pontefract","year":"2018","journal-title":"Innov Pharm"},{"issue":"4","key":"10.1016\/j.japh.2025.102413_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4321\/S1886-36552013000400005","article-title":"Clinical inertia in type 2 diabetes: A retrospective analysis of pharmacist-managed diabetes care vs. usual medical care","volume":"11","author":"Yam","year":"2013","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.japh.2025.102413_bib17","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.5888\/pcd17.190377","article-title":"Using an advanced practice pharmacist in a team-based care model to decrease time to hemoglobin A1c goal among patients with type 2 diabetes, Florida, 2017\u20132019","volume":"17","author":"Cowart","year":"2020","journal-title":"Prev Chronic Dis"},{"issue":"suppl 1","key":"10.1016\/j.japh.2025.102413_bib18","first-page":"S158","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.japh.2025.102413_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jdiacomp.2014.06.006","article-title":"Revisit frequency and its association with qualify of care among diabetic patients: Translating Research Into Action for Diabetes (TRIAD)","volume":"28","author":"Asao","year":"2014","journal-title":"J Diabetes Its Complications"},{"issue":"2","key":"10.1016\/j.japh.2025.102413_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2022-002229","article-title":"Impact of primary care usual provider type and provider interdependence on outcomes for patients with diabetes: a cohort study","volume":"12","author":"Everett","year":"2023","journal-title":"BMJ Open Qual"},{"issue":"4","key":"10.1016\/j.japh.2025.102413_bib21","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.18549\/PharmPract.2019.4.1618","article-title":"A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center","volume":"17","author":"Fink","year":"2019","journal-title":"Pharm Pract (Granada)"},{"issue":"5","key":"10.1016\/j.japh.2025.102413_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1345\/aph.1D359","article-title":"Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic","volume":"38","author":"Cioffi","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"suppl 1","key":"10.1016\/j.japh.2025.102413_bib23","first-page":"S111","article-title":"Glycemic goals and hypoglycemia","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.japh.2025.102413_bib24","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glycose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T23:13:59Z","timestamp":1754349239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1544319125000925"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102413","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to goal hemoglobin A1c with pharmacist management compared with nonpharmacist management","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"102413"}}